Skip to main content
. Author manuscript; available in PMC: 2013 Jul 18.
Published in final edited form as: Antivir Ther. 2012 Sep 28;17(7):1233–1242. doi: 10.3851/IMP2411

Figure 3.

Figure 3

Monocyte efficacy and central nervous system penetration effectiveness scores by cognitive status

(A) Monocyte efficacy (ME) scores. (B) Central nervous system penetration effectiveness (CPE) scores. Outliers are shown as black circles. HAD, HIV-associated dementia; MCMD, minor cognitive motor disorder; NP abnormal, neuropsychologically abnormal.